Background: Activated T helper type 2 (Th2) cells are believed to play a pivotal role
| MATERIAL AND METHODS

| Asthmatic patients and non-atopic controls
Post-mortem tissue samples were obtained from a death certificate study on fatal asthma in children and adolescents (n = 12) during 1976-1998 in Finland. 11, 12 Median age at death was 3.1 years (range 0. 9-19.5) . Of the individuals with reliable information, 4 of 6 cases had parents that were asthma sufferers. Nine of 12 asthmatic children displayed atopy. The median delay of anti-inflammatory medication from the beginning of asthma symptoms was 0.8 years, and only 5 of 12 patients were taking inhaled corticosteroids at the time of the fatal asthma attack (Table 1 ). The airways of the asthmatics showed typical signs of chronic Th2 inflammation, 13 including a marked thickening of the basement membrane of the epithelium and plugs of mucus in the lumen of bronchi and bronchioles. 12 Lung biopsies from 15 age-matched non-atopic individuals (median age 
| Allergic rhinitis patients
Birch pollen AR patients (n = 8, 20-25 year old, 5 women) were included. All patients fulfilled the Allergic Rhinitis and its Impact on Asthma (ARIA) criteria for persistent, moderate/severe AR 14 and had been symptomatic for at least the last three pollen seasons. All patients had a positive skin prick test to birch pollen. Five subjects were also sensitized to grass, mugwort, ragweed, mites and/or cat, dog or horse dander. Any other type of nasal disorder was excluded by examining the patients' medical histories and by clinical examination including nasal endoscopy. All patients were challenged according to the protocol shown in Figure S1 , and the provocation was 
| Nasal allergen challenge
The nasal challenge procedure has been described in detail elsewhere, 15 and the challenge protocol is shown in Figure S1 . 
| Nasal symptoms
The patients were instructed to score each single nasal symptom (sneezing, rhinorrhoea and nasal blockage) by using a 10 cm visual analogue scale ranging from "not bothered at all" to "extremely No biopsy-related complications occurred.
| Tissue preparation for immunohistology
Multi-colour immunofluorescence was performed as described elsewhere. 16 The monoclonal antibodies (mAbs) used are listed in Tables   S1 and S2 . Concentration-matched irrelevant isotype antibodies were used as negative controls. For immunohistochemical localization of S100A8/A9, a DAKO EnVision peroxidase/DAB kit (Agilent Kista, Sweden) was applied.
| Immunofluorescence microscopy
The slides were examined by IEG at x60 magnification with a confocal microscope. | 1633 respiratory mucosa. When studying the turnover of alveolar macrophages in transplanted lungs using FFPE specimens, we recently found that incoming recipient monocytes selectively expressed the antimicrobial protein S100A8/A9, whereas resident alveolar macrophages from the donor were uniformly S100A8/A9-negative. 17 Furthermore, we recently reported that blood monocytes constitutively migrate into the intestinal mucosa where they develop into mature macrophages, with a progressive loss of S100A8/A9 expression as part of the differentiation process. 18 To test the applicability of this marker in an airway allergy setting, we examined FFPE specimens of the nasal mucosa obtained from an experimental in vivo model of AR ( Figure S1 ) in which all allergen-challenged patients experienced typical allergic symptoms and increase in the density of mucosal eosinophils ( Figure S3 ). We have recently shown that monocytes rapidly accumulate in experimentally induced AR using cryo-preserved tissue material, 10 but in the latter study, we had no positive marker to identify monocytes and used DC-SIGN/CD209 to distinguish monocytes (negative) from macrophages (positive). Co-staining for S100A8/A9 and the pan monocyte/macrophage marker CD68, together with assessments of nuclear morphology to exclude granulocytes, on FFPE sections revealed few double-positive cells at baseline ( Figure 1A -C), but following two days of allergen provocation, there was a striking 11-fold increase in CD68+S100A8/A9+ monocytes, whereas the number of CD68+S100A8/A9-macrophages was unchanged ( Figure 1A-C) . Of note, there was a correlation between the accumulating monocytes and eosinophils in the nasal mucosa of AR patients (r = 0.5; P = 0.001), suggesting that monocyte recruitment associates with markers of airway allergic inflammation. This observation was consistent with our previous study, 10 and further substantiated the finding that monocytes are recruited in large numbers to the challenged nasal mucosa of AR patients, whereas the density of macrophages remains unchanged. The observation furthermore demonstrates the applicability of using S100A8/A9 as a marker to identify newly recruited monocytes in FFPE tissues.
| Monocytes accumulate in the lower airways of children and adolescents with fatal asthma attacks
To examine whether monocytes are recruited to the inflamed lungs of asthmatics, FFPE lung biopsies from children and adolescent with fatal asthma and lung specimens from age-matched control individuals were analysed. Co-staining for CD68 and S100A8/A9 revealed a 5-fold higher density (P = 0.0002) of monocytes in the lamina propria of the bronchi and bronchioles in asthmatic subjects compared to controls (Figure 2A ). The number of CD68+S100A8/A9-macrophages was also higher in asthmatics, yet the difference was less pronounced (3-fold increase, P = 0.0028) ( Figure 2B ). Importantly, F I G U R E 1 Co-staining for CD68 and S100A8/A9 discriminates recruited monocytes from resident macrophages in the airways of allergic patients. Density of CD68+S100A8/A9+monocytes (A) and CD68+S100A8/A9-macrophages (B) in the nasal mucosa of allergic rhinitis patients at baseline and after 2 days of allergen challenge. C, Two-colour immunofluorescence staining of CD68 and S100A8/A9 at baseline and after provocation. The yellow and white arrowheads indicate macrophages and monocytes, respectively (***P < 0.001).
Scale bars: 30 μm (Table 1) . There was no association between elicited monocytes and T lymphocytes or smooth muscle cells in the bronchial mucosa of asthmatics (data not shown), but there was a F I G U R E 2 Both monocytes and macrophages are increased in the bronchial mucosa of children with fatal asthma attacks. Density of CD68+S100A8/ A9+monocytes (A) and CD68+S100A8/9-macrophages (B) in the lamina propia of bronchial mucosal tissue from asthmatic children and non-atopic controls. Twocolour immunofluorescence staining of CD68 and S100A8/A9 on FFPE section from control and asthmatic patient (C). Yellow and white arrowheads indicate macrophages and monocytes. S100A8/ A9+CD68-cells represent granulocytes (**P < 0.01***P < 0.001). Scale bars: 30 μm F I G U R E 3 Aggregates of monocytes obstruct the airways of children with fatal asthma attacks. Haematoxylin-eosin staining of a FFPE section from a child suffering from fatal asthma attack showing a bronchiole with abundant mononuclear cells in the airway lumen (A).Twocolour immunofluorescence staining of CD68 and S100A8/A9 in an adjacent section (B) to that shown in A. The white arrows mark intraepithelial S100A8/A9+CD68+ mononuclear cells (monocytes). S100A8/A9+CD68-cells represent granulocytes. Scale bars: 50 μm EGUÍLUZ-GRACIA ET AL.
| 1635 significant correlation between monocytes and eosinophils (r = 0.684; P = 0.001) and between monocytes and the thickness of the basement membrane (r = 0.639; P = 0.002).
Interestingly, in 8 of 12 asthma subjects, but not in the controls, cellular aggregates containing CD68+S100A8/A9+ monocytes obstructing the lumen of bronchioles were found ( Figure 3) . Moreover, single monocytes between the basement membrane and the epithelial layer were observed ( Figure 3B ). Also in the parenchyma of asthmatic individuals, the density of CD68+S100A8/A9+ monocytes was higher (4-fold, P = 0.0002) than in control subjects (Figure 4A ), but the number of CD68+S100A8/A9-alveolar macrophages was comparable between the two groups ( Figure 4B ).
Most parenchymal monocytes in the lung of asthmatics appeared to reside within the interstitium ( Figure S5 ), but monocytes were also observed within the alveolar lumen ( Figure 4B ). As in the bronchi, neither the disease duration, age at death nor the anti-asthma therapy affected the accumulation of monocytes in the parenchyma of asthmatics (data not shown). Together, these observations imply that recruited monocytes are able to migrate from the vessels in the lamina propia to the airway lumen.
| Monocytes express MMP10 in allergic airway inflammation
We recently performed global transcriptomic analysis of sorted CD45+HLA-DR+ APCs in a short-term (48 hours) experimental model of human AR, in which we found a strong upregulation of several genes including matrix metalloproteinase 10 (MMP10) after provocation (Eguiluz-Gracia et al, unpublished). MMP10, also termed stromelysin-2, is an endopeptidase involved in the breakdown of extracellular matrices (ECMs) by cleaving proteoglycans and fibronectin. 19 MMP10 is also utilized by mouse bone marrow-derived macrophages to migrate through ECMs. 20 Interestingly, sorted peripheral blood monocytes from healthy adults uniformly expressed MMP10 ( Figure 5A ), and we thus hypothesized that accumulating monocytes may use this protein to migrate within the inflamed tissue. To this end, we performed three-colour immunofluorescence in situ staining for CD68, S100A8/A9 and MMP10.
Of note, we found that many CD68+S100A8/A9+ monocytes both in the lumen of small vessels and in the lamina propia expressed MMP10 in allergen-challenged AR patients ( Figure 5B ). As previously reported, monocytes are quite scarce in nasal mucosal samples obtained before provocation, 10 and only occasional MMP10+ monocytes were seen at baseline ( Figure S4 ). We then examined the occurrence of MMP10+ monocytes in FFPE tissue from asthmatic patients. In the lamina propia of bronchi and bronchioles, a median of 70% of CD68+S100A8/A9+ monocytes expressed MMP10, and the density of MMP10+ monocytes was 7-fold higher (P = 0.0002) than in control individuals ( Figure 5C -E).
Also in the lung parenchyma, 75% of CD68+S100A8/A9+ monocytes expressed MMP10, and the density was 4-fold higher (P = 0.0001) than in controls ( Figure 5F ,H). Taken together, these findings suggest that MMP10 expression might contribute to monocyte migration in the respiratory tract.
F I G U R E 4
Monocytes, but not alveolar macrophages, are increased in the lung parenchyma of children with fatal asthma attacks. Density of CD68+S100A8/A9+ monocytes (A) and CD68+S100A8/A9-macrophages (B) in the parenchyma of asthmatic children and non-atopic controls. Two-colour immunofluorescence staining of CD68 and S100A8/A9 on FFPE section from control and asthmatic patient samples. Yellow and white arrowheads indicate macrophages and monocytes, respectively. S100A8/A9+CD68-cells are granulocytes (***P < 0.001). Scale bars: 50 μm
The majority of monocytes in the respiratory tract of asthmatics express matrix metalloproteinase 10 (MMP10). PBMCs from a healthy donor were gated for CD14 (left panel), followed by intracellular staining of MMP10 vs isotype antibody (right panel) (A). Three-colour immunofluorescence staining of CD68, S100A8/A9 and MMP10 on FFPE section of the nasal mucosa from an AR patient after 2 days of allergen challenge (B). Density (C, E) and proportion (D, F) of MMP10+ monocytes in the bronchial lamina propia (C, D) and alveolar tissue (E, F) of asthma patients and non-atopic controls. Three-colour immunofluorescence staining of CD68, S100A8/A9 and MMP10 on FFPE sections in the bronchial lamina propia and pulmonary alveoli of representative asthmatic and control samples (G). The yellow, white and brown arrowheads indicate alveolar macrophages, MMP10+ monocytes and MMP10-monocytes, respectively. S100A8/A9+CD68-cells are granulocytes (***P < 0001). The robust recruitment of monocytes to the lungs of paediatric and adolescent patients with fatal asthma is consistent with a previous study of children hospitalized due to asthma exacerbations, which displayed increased numbers of activated monocytes in the circulation. 9 Furthermore, in a mouse model of asthma, incoming monocytes were identified as crucial local orchestrators during the effector phase of allergic inflammation, 8 whereas cDCs were more important for the initial sensitization process in the draining lymph nodes. Thus, it is reasonable to suggest that the massively elicited monocytes observed in the patients may play a similar role. Our study did not reveal striking differences in the number of lung-resident macrophages between asthmatics and non-atopic controls, suggesting that these cells do not have a prominent role during fatal asthma attacks. Although our study is limited by a relatively small sample size of autopsy material, the expression levels of the markers used to identify cell subsets were reportedly not significantly altered within the 48 hours' post-mortem. 23, 24 In this study, it was not possible to identify the final fate of the recruited monocytes. Mouse models indicate that most monocytes recruited during acute lung injury experience apoptosis as inflammation resolves. 25 However, a recent study of human duodenal transplants suggested that monocytes migrating to the mucosae during homoeostasis differentiate into macrophages, characterized by a maturation process involving S100A8/A9 downregulation and the progressive decrease in responsiveness to pro-inflammatory stimuli. 18 Moreover, inflammation of mucosal tissues supports a highly increased recruitment of monocytes and alters their final differentiation from regulatory macrophages to inflammatory monocytes, 8, 26, 27 underscoring that the developmental fate of incoming monocytes is highly dependent on the tissue environment upon migration. Mouse models also indicate that lung-resident DCs might partially arise from blood monocytes during the steady state, 28, 29 but robust markers applicable to histological sections for separation of monocytederived macrophages and DCs are not available. Moreover, lymph node homing capacity and T-cell stimulatory potential cannot be inferred from tissue staining. Although functional data are lacking, our finding of monocytes accumulation in the lower airways of fatal asthma attacks more likely reflects that inflammatory events in the asthmatic lung promote a large influx of monocytes that become "arrested" in a pro-inflammatory state. Importantly, the correlation between monocyte infiltration in the bronchial mucosa and the thickness of the basement membrane of the bronchial epithelium suggests that these cells might contribute not only to the inflammatory reaction, but also to the remodelling processes.
We also found that CD68+S100A8/A9+ monocytes accumulated in the alveolar walls of asthmatics, and that some of them were able to migrate to the airway lumen. Previous studies have reported an influx of lymphocytes and eosinophils into alveolar tissue of asthma patients. 30 The recruitment of monocytes to the lung parenchyma after allergen challenge had been previously identified in mouse models of asthma, 31 but data from human asthmatic lungs have been lacking. Together, these findings identify the alveolar compartment as an active site of inflammation during severe asthma. A recent study showed that adult patients with fatal asthma attacks display increased numbers of myofibroblasts in the lung parenchyma, 32 suggesting that this anatomical compartment could also be affected by the tissue remodelling process.
Migration of cells within the tissue depends on several factors including the expression of MMPs with the ability to cleave the large biomolecules of the ECM, thus facilitating the movement of migrating cells. 20, 33 Interestingly, we found that most of the accumulating monocytes expressed MMP10. Recently, MMP10 was reported to be expressed by mouse bone marrow-derived macrophages during experimental models of inflammation 20, 34 ; thus, MMP10 might play a role in the motility of monocytes that accumulated in the peripheral airways.
Our results suggest that CD68+S100A8/A9+ monocytes constitute potential therapeutic targets for airway allergy. In this regard, the inhibition of monocytes is probably one of the multiple actions of inhaled corticosteroids in asthma. 35 Moreover, mouse models suggest that blocking monocyte recruitment by targeting CCR2 reduces lung inflammation in asthma. 8 Additionally, MMP10 antagonism might substantially reduce monocyte migration within the inflamed lungs. Further research exploring the therapeutic potential of antagonizing the recruitment and migration of monocytes in human airway allergy may provide new therapeutic approaches for severe asthma.
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